官方服务：
资源简介：
VCaP_AR_ENZ3w_1nM-DHT_rep2
应用场景：
创建时间：
2023-03-09
相关数据集
Effects of Oct1 inhibition in AR signaling
Prostate cancer is the most common cancer in men and AR downstream signalings promote prostate cancer cell proliferation. Oct1 is an AR interacting partner and regulates the transcriptional activity o
NIAID Data Ecosystem190
Metformin inhibits the progression of prostate cancer by in-ducing purine metabolic alters and enhancing the PDE6D / cGMP / PKG pathway. Homo sapiens
The goals of this study is to find effect of metformin in prostate cancer cell (PC-3 cell line).
NIAID Data Ecosystem60
Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment. Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment
The gene expression profiling between Control and Luteolin in 22Rv1 Overall design: Two-condition experiment, Control vs. Luteolin. 22Rv1 cells were treated 25 μM luteolin for 48 hours.
NIAID Data Ecosystem30
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance. GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance
Genomic amplification of the androgen receptor (AR) is an established mechanism of antiandrogen resistance in prostate cancer. Here we show that the magnitude of AR signaling output, independent of AR
NIAID Data Ecosystem70
Dissecting cell-type-specific roles of androgen receptor in prostate homeostasis and regeneration through lineage tracing. Mus musculus
We used RNA-seq to compare the gene expression profiles of adult mouse prostate luminal cells and luminal cells that have the androgen receptor (AR) gene deleted. Our analyses show that AR-null lumina
NIAID Data Ecosystem40
